Apricus Biosciences (APRI) Enters Agreement to Bring ED Drug Vitaros to Part of the Middle East
Tweet Send to a Friend
Apricus Biosciences, Inc. (Nasdaq: APRI) and Elis Pharmaceuticals announced that they have entered into a licensing agreement which would allow ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
